SMTL ID : 7n7k.1

Crystal Structure of PI5P4KIIAlpha complex with AMPPNP

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.00 Å

Oligo State

homo-dimer

Ligands

4 x MN: MANGANESE (II) ION(Non-covalent)

MN.1: 3 residues within 4Å: Chain A: D.331 Ligands: MN.2, ANP.3 2 PLIP interactions: 1 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.331, H2O.1 MN.2: 4 residues within 4Å: Chain A: K.117, D.331 Ligands: MN.1, ANP.3 3 PLIP interactions: 2 interactions with chain A, 1 Ligand-Water interactions Metal complexes: A:D.331, A:D.331, H2O.1 MN.7: 3 residues within 4Å: Chain B: D.331 Ligands: MN.8, ANP.9 2 PLIP interactions: 1 interactions with chain B, 1 Ligand-Water interactions Metal complexes: B:D.331, H2O.9 MN.8: 4 residues within 4Å: Chain B: K.117, D.331 Ligands: MN.7, ANP.9 3 PLIP interactions: 2 interactions with chain B, 1 Ligand-Water interactions Metal complexes: B:D.331, B:D.331, H2O.8

2 x ANP: PHOSPHOAMINOPHOSPHONIC ACID-ADENYLATE ESTER(Non-covalent)

ANP.3: 18 residues within 4Å: Chain A: S.98, A.100, A.104, F.106, I.115, K.117, T.168, R.169, N.170, V.171, K.181, D.183, T.204, L.249, I.330, D.331 Ligands: MN.1, MN.2 11 PLIP interactions: 11 interactions with chain A Hydrogen bonds: A:S.98, A:K.117, A:T.168, A:R.169, A:V.171, A:K.181, A:D.183, A:T.204 Water bridges: A:Q.99, A:K.185 Salt bridges: A:K.117 ANP.9: 18 residues within 4Å: Chain B: S.98, A.100, A.104, F.106, I.115, K.117, T.168, R.169, N.170, V.171, K.181, D.183, T.204, L.249, I.330, D.331 Ligands: MN.7, MN.8 13 PLIP interactions: 13 interactions with chain B Hydrogen bonds: B:S.98, B:K.117, B:T.168, B:R.169, B:V.171, B:K.181, B:D.183, B:D.183, B:T.204, B:T.204 Water bridges: B:Q.99, B:K.185 Salt bridges: B:K.117

6 x SO4: SULFATE ION(Non-functional Binders)

SO4.4: 2 residues within 4Å: Chain A: K.185, R.191 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:K.185, A:R.191 SO4.5: 3 residues within 4Å: Chain A: K.43, R.155 Ligands: SO4.6 2 PLIP interactions: 2 interactions with chain A Salt bridges: A:K.43, A:R.155 SO4.6: 6 residues within 4Å: Chain A: K.43, K.45, K.61 Chain B: K.45, D.47 Ligands: SO4.5 4 PLIP interactions: 2 interactions with chain B, 2 interactions with chain A Water bridges: B:D.47 Salt bridges: B:K.45, A:K.43, A:K.61 SO4.10: 2 residues within 4Å: Chain B: K.185, R.191 2 PLIP interactions: 2 interactions with chain B Salt bridges: B:K.185, B:R.191 SO4.11: 3 residues within 4Å: Chain B: K.43, R.155 Ligands: SO4.12 2 PLIP interactions: 2 interactions with chain B Salt bridges: B:K.43, B:R.155 SO4.12: 6 residues within 4Å: Chain A: K.45, D.47 Chain B: K.43, K.45, K.61 Ligands: SO4.11 5 PLIP interactions: 3 interactions with chain A, 2 interactions with chain B Water bridges: A:D.47, A:D.47 Salt bridges: A:K.45, B:K.43, B:K.61

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Chen, S. et al., Pharmacological inhibition of PI5P4K alpha / beta disrupts cell energy metabolism and selectively kills p53-null tumor cells. Proc.Natl.Acad.Sci.USA (2021)

Release Date

2021-06-30

Peptides

Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha: AB

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
A

Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha

Related Entries With Identical Sequence